The Team

Principal Investigator

Dr. Carlos Camara completed his internal medicine and neurology residencies at the UANL University Hospital in Monterrey, Mexico. He subsequently completed a two-year MS and Neuroimmunology fellowship at the University of Calgary. 
His current research interests include the gut-brain axis, biomarkers and neuroprotection in MS and neuroinflammatory disorders of the CNS. The main focus of this work is translational, where basic neuroscience research is developed into clinical applications and novel therapies for MS and related disorders.

Dr. Aravind Ganesh is a Vascular and Cognitive Neurologist. He completed his MD degree at the University of Calgary, followed by a DPhil in Clinical Neurosciences at the University of Oxford’s Centre for Prevention of Stroke and Dementia as a Rhodes scholar. He earned an Associate Fellowship from the United Kingdom’s Higher Education Academy through his teaching contributions at St John’s College (Oxford). He completed his neurology residency in Calgary, followed by a combined fellowship in stroke and cognitive neurology, funded by Alberta Innovates and the Canadian Institutes of Health Research. Dr. Ganesh is a Fellow of the Canadian Stroke Consortium, and is actively involved in the development of best-practice guidelines for stroke and dementia care. His clinical research is focused on the natural history, prevention, and treatment of stroke and cognitive impairment, including behavioural and neuropsychiatric sequelae.